Infectious Diseases I
Wound Infection
Anaya DA, Dellinger EP. Necrotizing soft-tissue infec-
tion: diagnosis and management. Clin Infect Dis.
2007;44(5):705-710. https://doi.org/10.1086/511638
Calderwood MS, Anderson DJ, Bratzler DW, et al.
Strategies to prevent surgical site infections in acute-care
hospitals: 2022 update. Infect Control Hosp Epidemiol.
2023;44(5):695-720. https://doi.org/10.1017/ice.2023.67
Dorazio J, Chiappelli AL, Shields RK, et al. Clindamycin
plus vancomycin versus linezolid for treatment of nec-
rotizing soft tissue infection. Open Forum Infect Dis.
2023;10(6):ofad258. https://doi.org/10.1093/ofid/ofad258
Lappin E, Ferguson AJ. Gram-positive toxic shock syn-
doi.org/10.1016/s1473-3099(09)70066-0
May AK, Stafford RE, Bulger EM, et al. Treatment of
complicated skin and soft tissue infections. Surg Infect
sur.2009.012
Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/
SIS-E consensus conference: recommendations for the
management of skin and soft-tissue infections. World
J Emerg Surg. 2018;13:58. https://doi.org/10.1186/
s13017-018-0219-9
Stevens DL, Bisno AL, Chambers HF, et al. Practice
guidelines for the diagnosis and management of
skin and soft tissue infections: 2014 update by the
Infectious Diseases Society of America. Clin Infect Dis.
2014;59(2):e10-e52. https://doi.org/10.1093/cid/ciu444
Influenza
Centers for Disease Control and Prevention. Signs and
symptoms of flu. 2024. https://www.cdc.gov/flu/signs-
symptoms/index.html
Centers for Disease Control and Prevention. Rapid influ-
enza diagnostic tests. 2024. https://www.cdc.gov/flu/hcp/
testing-methods/clinician_guidance_ridt.html
Centers for Disease Control and Prevention. FluView:
a weekly influenza surveillance report prepared by the
Influenza Division. https://www.cdc.gov/fluview/index.
html
Centers for Disease Control and Prevention. Influenza
antiviral medications: summary for clinicians. 2023.
https://www.cdc.gov/flu/hcp/antivirals/summary-clini-
cians.html
de Jong MD, Ison MG, Monto AS, et al. Evaluation of
intravenous peramivir for treatment of influenza in hos-
pitalized patients. Clin Infect Dis. 2014;59(12):e172-e185.
https://doi.org/10.1093/cid/ciu632
Flannery AH, Thompson Bastin ML. Oseltamivir
dosing in critically ill patients with severe influenza.
org/10.1177/1060028014535362
Harper SA, Bradley JS, Englund JA, et al. Seasonal
influenza in adults and children—diagnosis, treat-
ment, chemoprophylaxis, and institutional outbreak
management: clinical practice guidelines of the
Infectious Diseases Society of America. Clin Infect Dis.
2009;48(8):1003-1032. https://doi.org/10.1086/598513
Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-
Tam J, Shen Lim W. Corticosteroids as adjunctive therapy
in the treatment of influenza: an updated Cochrane
Med.
2020;48(2):e98-e106.
https://doi.org/10.1097/
ccm.0000000000004093
Rothberg MB, Haessler SD. Complications of sea-
2010;38(4
suppl):e91-e97.
https://doi.org/10.1097/
ccm.0b013e3181c92eeb
Tsai MJ, Yang KY, Chan MC, et al. Impact of
corticosteroid treatment on clinical outcomes of influ-
enza-associated ARDS: a nationwide multicenter
org/10.1186/s13613-020-0642-4
Severe Acute Respiratory Syndrome Coronavirus 2
Alhazzani W, Evans L, Alshamsi F, et al. Surviving
Sepsis Campaign guidelines on the management of
adults with coronavirus disease 2019 (COVID-19) in the
https://doi.org/10.1097/ccm.0000000000004899
Beigel JH, Tomashek KM, Dodd LE. Remdesivir for the
treatment of Covid-19—preliminary report. Reply. N
Engl J Med. 2020;383(10):994. https://doi.org/10.1056/
nejmc2022236
Chen X, Zhu Y, Shen L, Zhou D, Feng N, Tong Q.
Efficacy and safety of nirmatrelvir/ritonavir in severe
hospitalized patients with COVID-19 and in patients at
high risk for progression to critical illness: a real-world
doi.org/10.1177/08850666241228841